Marta Radaelli
Marta Radaelli has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Vittorio Martinelli
Neurology Unit, IRCCS Ospedale San Raffaele, Milano, Italy
4 shared publications - Lucia Moiola
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications - Massimo Filippi
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications - Elisabetta Pagani
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
2 shared publications - Giancarlo Comi
San Raffaele University, Milan, Italy
2 shared publications - Jelena Drulovic
Clinic of Neurology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia
2 shared publications
Latest Publications
- Open Access
JOINT APPLICATION OF BRAIN MRI AND GENE EXPRESSION ATLAS TO RECONSTRUCT NMOSD PATHOPHYSIOLOGY
Objective Brain lesions in aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) occur at areas of high AQP4 expression. However, the pathophysiological cascade requires additional factors such as complement. We sought to investigate the spatial association between brain damage and gene expression in AQP4+NMOSD. Methods In this multicenter cross-sectional study, we enrolled 90 patients and 94 age-matched healthy controls who underwent a 3.0/1.5 T brain MRI. In patients, brain damage was assessed through (i) T2-hyperintense lesion probability maps, (ii) white matter (WM) and grey matter (GM) atrophy on 3D T1-weighted sequences, and (iii) WM microstructural abnormalities on diffusion-tensor imaging. The association between imaging maps and the expression of 266 candidate genes in the Allen Human Brain Atlas was obtained and overrepresented biological processes were investigated with a functional-enrichment analysis. Results In AQP4+NMOSD, T2-hyperintense lesions were mainly located in the periventricular WM. GM and WM atrophy involved the visual pathway, while WM microstructural abnormalities were represented by a widespread increase of mean diffusivity. The expression of AQP4, C4a and C5 elements of complement resulted associated with all types of brain damage. Complement activation and the regulation and uptake of insulin-like growth factor were the most relevant enriched pathways. Non-specific pathways related to DNA synthesis and repair were associated with brain atrophy. Interpretation A joint application of quantitative MRI and gene expression atlas can identify in vivo the key elements of AQP4+NMOSD pathophysiology. This may pave the way to a novel type of imaging analysis helpful in understanding the pathophysiology of antibody-mediated autoimmune disorders.
Open AccessJOINT APPLICATION OF BRAIN MRI AND GENE EXPRESSION ATLAS TO RECONSTRUCT NMOSD PATHOPHYSIOLOGY
Objective Brain lesions in aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) occur at areas of high AQP4 expression. However, the pathophysiological cascade requires additional factors such as complement. We sought to investigate the spatial association between brain damage and gene expression in AQP4+NMOSD. Methods In this multicenter cross-sectional study, we enrolled 90 patients and 94 age-matched healthy controls who underwent a 3.0/1.5 T brain MRI. In patients, brain damage was assessed through (i) T2-hyperintense lesion probability maps, (ii) white matter (WM) and grey matter (GM) atrophy on 3D T1-weighted sequences, and (iii) WM microstructural abnormalities on diffusion-tensor imaging. The association between imaging maps and the expression of 266 candidate genes in the Allen Human Brain Atlas was obtained and overrepresented biological processes were investigated with a functional-enrichment analysis. Results In AQP4+NMOSD, T2-hyperintense lesions were mainly located in the periventricular WM. GM and WM atrophy involved the visual pathway, while WM microstructural abnormalities were represented by a widespread increase of mean diffusivity. The expression of AQP4, C4a and C5 elements of complement resulted associated with all types of brain damage. Complement activation and the regulation and uptake of insulin-like growth factor were the most relevant enriched pathways. Non-specific pathways related to DNA synthesis and repair were associated with brain atrophy. Interpretation A joint application of quantitative MRI and gene expression atlas can identify in vivo the key elements of AQP4+NMOSD pathophysiology. This may pave the way to a novel type of imaging analysis helpful in understanding the pathophysiology of antibody-mediated autoimmune disorders.
- 28 April 2022
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 93 (7) , 753-760
MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD
Objective: Since astrocytes at the blood–brain barrier are targeted by neuromyelitis optica spectrum disorder (NMOSD), this study aims to assess whether patients with NMOSD have a subclinical accumulation of brain water and if it differs according to disease activity.Methods: Seventy-seven aquaporin-4-positive patients with NMOSD and 105 healthy controls were enrolled at two European centres. Brain dual-echo turbo spin-echo MR images were evaluated and maps of T2 relaxation time (T2rt) in the normal-appearing white matter (NAWM), grey matter and basal ganglia were obtained. Patients with a clinical relapse within 1 month before or after MRI acquisition were defined ‘active’. Differences between patients and controls were assessed using z-scores of T2rt obtained with age-adjusted and sex-adjusted linear models from each site. A stepwise binary logistic regression was run on clinical and MRI variables to identify independent predictors of disease activity.Results: Patients had increased T2rt in both white and grey matter structures (p range: 0.014 to 2=0.46, p<0.001).Conclusions: In line with the research hypothesis, patients with NMOSD have increased brain T2rt. The magnitude of this alteration might be useful for identifying those patients with active disease.
- 28 April 2022
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 93 (7) , 753-760
MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD
Objective: Since astrocytes at the blood–brain barrier are targeted by neuromyelitis optica spectrum disorder (NMOSD), this study aims to assess whether patients with NMOSD have a subclinical accumulation of brain water and if it differs according to disease activity.Methods: Seventy-seven aquaporin-4-positive patients with NMOSD and 105 healthy controls were enrolled at two European centres. Brain dual-echo turbo spin-echo MR images were evaluated and maps of T2 relaxation time (T2rt) in the normal-appearing white matter (NAWM), grey matter and basal ganglia were obtained. Patients with a clinical relapse within 1 month before or after MRI acquisition were defined ‘active’. Differences between patients and controls were assessed using z-scores of T2rt obtained with age-adjusted and sex-adjusted linear models from each site. A stepwise binary logistic regression was run on clinical and MRI variables to identify independent predictors of disease activity.Results: Patients had increased T2rt in both white and grey matter structures (p range: 0.014 to 2=0.46, p<0.001).Conclusions: In line with the research hypothesis, patients with NMOSD have increased brain T2rt. The magnitude of this alteration might be useful for identifying those patients with active disease.
- Open Access
- 7 May 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (5) , e16043
Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study
Background: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, “off-the-shelf” devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. Objective: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. Methods: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. Results: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. Conclusions: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.
- 7 May 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (5) , e16043
Open AccessHuman-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study
Background: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, “off-the-shelf” devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. Objective: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. Methods: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. Results: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. Conclusions: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.
- Open Access
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 58-60
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 58-60
Open AccessNecrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e219-e220
[PP.16.07] CVD RISK IS INDEPENDENTLY ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE (BP) IN PATIENTS WITH TYPE 2 DIABETES
Objective: Recent evidence suggest that CVD risk is related also on the consistency of BP control between on-treatment visits. Visit-to-visit variability of systolic BP is a biomarker of arterial stiffness, autonomic dysfunction, endothelial damage and systemic inflammation but it may also reflect poor patients’ adherence to the pharmacologic therapy. Design and method: We analyzed the relationships between micro-and macro-vascular complications of diabetes in 818 patients attending at least four times our secondary care diabetes clinic between 2013–15 with the standard deviation of the visit-to-visit variability of sitting systolic BP. We segregated these patients in tertiles of the standard deviation of visit-to-visit variability. Results: Patients with the high visit-to-visit variability were older (p < 0.0001), with higher waist circumference (p < 0.022), higher systolic (136 ± 17, 138 ± 15 and 142 ± 14 mm Hg; p < 0.0001), but not diastolic (79 ± 9, 78 ± 10 and 78 ± 9 mm Hg; p = 0.56) blood pressure and heart rate (78 ± 12, 78 ± 10 and 77 ± 9; p = 0.32). Glycemic control was not different between tertiles, meanwhile estimated GFR was lower in the tertile with high visit-to-visit variability of BP (p < 0.0001). Diabetic retinopathy (19%, 17% and 26%; p < 0.05) but not microalbuminuria (32%, 36% and 37%; p < 0.48) was more frequent in those with high visit-to-visit variability of BP. Established CVD was more prevalent in patients with high variability (35%, 50%, 72%; p < 0.0001). Treatments with statin (61%, 76% and 74%; p < 00001) and anti-hypertensive drugs (ACE-inhibitors and Ca antagonists in particular) were also more frequent in patients with high variability. When multivariate analysis of regression was performed with the 10 year UKPDS Risk Engine used as dependent variable, visit-to-visit variability of BP was independently associated with the risks of coronary heart disease, fatal CHD, and more tightly with the risks of stroke and fatal stroke also when adjusted for max systolic blood pressure and drug therapy. Conclusions: The results of this analysis support the hypothesis that in patient with type 2 diabetes a lack of stable control of ambulatory BP is related to established CVD and increased risk of CVD events.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e219-e220
[PP.16.07] CVD RISK IS INDEPENDENTLY ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE (BP) IN PATIENTS WITH TYPE 2 DIABETES
Objective: Recent evidence suggest that CVD risk is related also on the consistency of BP control between on-treatment visits. Visit-to-visit variability of systolic BP is a biomarker of arterial stiffness, autonomic dysfunction, endothelial damage and systemic inflammation but it may also reflect poor patients’ adherence to the pharmacologic therapy. Design and method: We analyzed the relationships between micro-and macro-vascular complications of diabetes in 818 patients attending at least four times our secondary care diabetes clinic between 2013–15 with the standard deviation of the visit-to-visit variability of sitting systolic BP. We segregated these patients in tertiles of the standard deviation of visit-to-visit variability. Results: Patients with the high visit-to-visit variability were older (p < 0.0001), with higher waist circumference (p < 0.022), higher systolic (136 ± 17, 138 ± 15 and 142 ± 14 mm Hg; p < 0.0001), but not diastolic (79 ± 9, 78 ± 10 and 78 ± 9 mm Hg; p = 0.56) blood pressure and heart rate (78 ± 12, 78 ± 10 and 77 ± 9; p = 0.32). Glycemic control was not different between tertiles, meanwhile estimated GFR was lower in the tertile with high visit-to-visit variability of BP (p < 0.0001). Diabetic retinopathy (19%, 17% and 26%; p < 0.05) but not microalbuminuria (32%, 36% and 37%; p < 0.48) was more frequent in those with high visit-to-visit variability of BP. Established CVD was more prevalent in patients with high variability (35%, 50%, 72%; p < 0.0001). Treatments with statin (61%, 76% and 74%; p < 00001) and anti-hypertensive drugs (ACE-inhibitors and Ca antagonists in particular) were also more frequent in patients with high variability. When multivariate analysis of regression was performed with the 10 year UKPDS Risk Engine used as dependent variable, visit-to-visit variability of BP was independently associated with the risks of coronary heart disease, fatal CHD, and more tightly with the risks of stroke and fatal stroke also when adjusted for max systolic blood pressure and drug therapy. Conclusions: The results of this analysis support the hypothesis that in patient with type 2 diabetes a lack of stable control of ambulatory BP is related to established CVD and increased risk of CVD events.
- 24 April 2012
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (3) , 393-396
Practice of yoga may cause damage of both sciatic nerves: a case report
Sciatic nerve traumatic damage very rarely occurs bilaterally. We describe the case of a 67-year-old woman who reported a bilateral traumatic lesion of the sciatic nerve during practice of yoga. Nerve conduction studies showed a bilateral sciatic nerve neuropathy, mostly affecting the peroneal component. Lumbar plexus MRI documented regular anatomical features of the main principal nerve roots with bilateral T2 signal alteration of roots L4, L5 and S1 that extended into the sciatic nerves showing both increase in size, probably related to chronic injury of nerves, and an alteration in diffusion signal that suggested a recent acute overlapped process.
- 24 April 2012
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (3) , 393-396
Practice of yoga may cause damage of both sciatic nerves: a case report
Sciatic nerve traumatic damage very rarely occurs bilaterally. We describe the case of a 67-year-old woman who reported a bilateral traumatic lesion of the sciatic nerve during practice of yoga. Nerve conduction studies showed a bilateral sciatic nerve neuropathy, mostly affecting the peroneal component. Lumbar plexus MRI documented regular anatomical features of the main principal nerve roots with bilateral T2 signal alteration of roots L4, L5 and S1 that extended into the sciatic nerves showing both increase in size, probably related to chronic injury of nerves, and an alteration in diffusion signal that suggested a recent acute overlapped process.